Fosamax

The drug Fosamax (generic: Alendronate) is currently being prescribed as a treatment for Osteoporosis, Paget’s disease, and for use in conjunction with chemotherapy. It is a biphosphonate and is designed to prevent bone breakdown and increase bone density. The drug is very widely used and Merck, the drug’s manufacturer, expects sales of Fosamax to reach $3.6 billion this year alone.

But recently, evidence has linked the use of Fosamax to a rare and incurable disease known as Osteonecrosis of the jaw. The disease initially warns of its presence with persistent, unhealing legions in the mouth, or pain under the eyes in the cheekbones. Eventually, the lesions open enough to expose the bone to infection, which causes the eventual death of the bone. Once the bone is dead, no significant treatment options exist. This process of Osteonecrosis of the jaw is typically irreversible once it has reached a certain critical point, and it is necessary for those taking Fosamax to closely monitor their mouths for the early warning signs. Dentists have begun refusing to treat patients who are taking Fosamax for fear of initiating the process of Osteonecrosis of the jaw, and those taking the drug should proceed very carefully with regard to injuries involving the mouth. The FDA has asked Merck to warn consumers about the dangers this drug presents.

If you have taken Fosamax in the past or are taking it currently and believe you show any of the symptoms mentioned above, it is important to talk to your doctor immediately. If you think you have been injured by Fosamax and may have a case, please contact Daniel Gallucci by calling toll-free 1-888-245-0200

« Learn more about product liability litigation

E-Mail | Site Map | Disclaimer

RodaNast, PC

801 Estelle Drive
Lancaster, PA 17601 Phone: (717) 892-3000
Fax: (717) 892-1200

Call Us Toll Free
1-888-245-0200

Map, Hours and Directions